{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:05:09Z","timestamp":1783595109267,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T00:00:00Z","timestamp":1520726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.gore.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:03:18Z","timestamp":1521403398000},"page":"39-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Lorena","family":"Losi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Botticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Taccagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Longinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Scurani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2018.03.003_bb0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gore.2018.03.003_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Andrici","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gore.2018.03.003_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2013.03.021","article-title":"Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?","volume":"130","author":"Auersperg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2018.03.003_bb0020","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.gore.2018.03.003_bb0025","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Comin","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gore.2018.03.003_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.gore.2018.03.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gore.2018.03.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.gore.2018.03.003_bb0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer \u2014 shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gore.2018.03.003_bb0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.gore.2018.03.003_bb0055","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/annonc\/mdw089","article-title":"The molecular pathology of ovarian serous borderline tumors","volume":"27","author":"Malpica","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gore.2018.03.003_bb6660","series-title":"AJCC Cancer Staging Manual","first-page":"681","article-title":"Ovary, falloppian tube, and primary peritoneal carcinoma","author":"Prat","year":"2017"},{"key":"10.1016\/j.gore.2018.03.003_bb0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1447-0756.2010.01272.x","article-title":"Development of the genital ducts and external genitalia in the early human embryo","volume":"36","author":"Sajjad","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.gore.2018.03.003_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/carcin\/bgp007","article-title":"Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes","volume":"30","author":"Sasaki","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gore.2018.03.003_bb0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcb.240590928","article-title":"Pathology of ovarian cancer precursors","volume":"99","author":"Scully","year":"1995","journal-title":"J. Cell. Biochem. Suppl."},{"key":"10.1016\/j.gore.2018.03.003_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4161\/cc.9.1.10264","article-title":"Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment","volume":"9","author":"Zheng","year":"2010","journal-title":"Cell Cycle"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578918300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578918300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:54:15Z","timestamp":1762480455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578918300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"alternative-id":["S2352578918300201"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2018.03.003","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}